Cargando…
Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice
Increasing numbers of patients with zoster were reported recently, and recombinant zoster vaccine (Shingrix(®)) was licensed using the AS01(B) adjuvant system. Although it induces highly effective protection, a high incidence of local adverse events (regional pain, erythema, and swelling) has been r...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413309/ https://www.ncbi.nlm.nih.gov/pubmed/36016227 http://dx.doi.org/10.3390/vaccines10081339 |